Poor correlation between intestinal and hepatic metabolic rates of CYP3A4 substrates in rats.
- 1 January 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 20 (5), 745-748
- https://doi.org/10.1023/a:1023429401738
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Evaluation of increased bioavailability of tacrolimus in rats with experimental renal dysfunctionJournal of Pharmacy and Pharmacology, 2002
- Effect of experimental renal dysfunction on bioavailability of ajmaline in ratsJournal of Pharmacy and Pharmacology, 2001
- Metabolic characterization of the major human small intestinal cytochrome p450s.2001
- Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans.2000
- Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesBritish Journal of Clinical Pharmacology, 1998
- Expression of Four Rat CYP2D Isoforms inSaccharomyces cerevisiaeand Their Catalytic SpecificityArchives of Biochemistry and Biophysics, 1997
- In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats.1996
- Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*Clinical Pharmacology & Therapeutics, 1996
- Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissuesBiochemical Pharmacology, 1995
- Oxidation of quinidine by human liver cytochrome P-450.1986